How much funding has Cellens Inc raised?

Cellens Inc has raised $6.5M in total funding, most recently a Seed round.

When was Cellens Inc founded?

Cellens Inc was founded in 2021.

Where is Cellens Inc headquartered?

Cellens Inc is headquartered in Boston, Massachusetts, United States.

What industry is Cellens Inc in?

Cellens Inc operates in Biotech, Healthcare, Medical Diagnostics, Oncology.

How many employees does Cellens Inc have?

Cellens Inc has 1-10 employees.

Cellens Inc

Q: Who are Cellens Inc's investors?

Cellens Inc's investors include SOSV, American Cancer Society BrightEdge Fund, KOLON, Tufts University, Labcorp.

Sensing Cancer on a Nanoscale Level

Boston, United States · Founded 2021 · $6.5M raised

Headquarters: Boston, Massachusetts
Employees: 1–10
Founded: 2021
Business Model: B2B

Website: cellensinc.com
Total Funding: $6.5M
Last Round: $6.5M SeedDec 2025
Rounds: 1

About

Cellens is a Boston-based Tufts University spinout pioneering a non-invasive cancer diagnostics platform that uses nanoscale mechanobiology and machine learning to detect bladder cancer from urine samples. Its Octosense platform scans cell surfaces at nanoscale resolution to identify unique biophysical fingerprints of cancer cells. The company raised a $6.5M seed round in December 2025 to advance its AI-driven diagnostic technology.

Summary

Cellens Inc is a Biotech company based in Boston, United States, founded in 2021. It has raised $6.5M in total across 1 round, most recently a $6.5M Seed round in Dec 2025. Investors include SOSV, American Cancer Society BrightEdge Fund and KOLON.